{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "853371", "DateCompleted": {"Year": "1977", "Month": "06", "Day": "22"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0022-3549", "JournalIssue": {"Volume": "66", "Issue": "4", "PubDate": {"Year": "1977", "Month": "Apr"}}, "Title": "Journal of pharmaceutical sciences", "ISOAbbreviation": "J Pharm Sci"}, "ArticleTitle": "Cytotoxic and tumor inhibitory agent from Polygala macradenia Gray (Polygalaceae): 4'-demethyldeoxypodophyllotoxin.", "Pagination": {"StartPage": "586", "EndPage": "587", "MedlinePgn": "586-7"}, "Abstract": {"AbstractText": ["The chloroform fraction of Polygala macradenia exhibited activity against the P-388 lymphocytic leukemia and human epidermoid carcinoma of the nasopharynx test systems. The constituent responsible for this activity was a lignan, 4'-demethyldeoxypodophyllotoxin (C21H20O7). The identity was proven by elemental analysis; PMR, IR, mass spectrometric, and melting-point determinations; and preparation of a derivative."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Hoffmann", "ForeName": "J J", "Initials": "JJ"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wiedhopf", "ForeName": "R M", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cole", "ForeName": "J R", "Initials": "JR"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Pharm Sci", "NlmUniqueID": "2985195R", "ISSNLinking": "0022-3549"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "L36H50F353", "NameOfSubstance": "Podophyllotoxin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia, Experimental"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms, Experimental"}, {"QualifierName": ["analysis"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["analogs & derivatives", "isolation & purification", "pharmacology"], "DescriptorName": "Podophyllotoxin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1977", "Month": "4", "Day": "1"}, {"Year": "1977", "Month": "4", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1977", "Month": "4", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["853371", "10.1002/jps.2600660433", "S0022-3549(15)39304-7"]}}]}